China's Sinovac COVID-19 vaccine has been approved for emergency use among population aged between 3 and 17 years old, after phase-II clinic trial data suggests it is at least 98.9 percent effective in producing antibodies, a higher efficacy than in population over 18 years old. The experiment included...More

Dear members of the Korean Children’s Union across the country, Dear delegates to the Joint National Meeting held in celebration of the 66th anniversary of the founding of the KCU, I am very happy and pleased today to see you, our proud KCU delegates, who have come from...More

The world's first trial results on minors aged 3-17 showed China's inactivated COVID-19 vaccine produced by Sinovac had good safety, tolerability, and immunogenicity in youths aged 3-17 years, the Global Times learnt from Sinovac on Tuesday. Observers believe the results will inspire the ongoing trial of other COVID-19...More

Children of the Revolution: Future of the Socialist DPR Korea (Video)More

Dear members of the Korean Children’s Union across the country, Dear delegates to the Joint National Meeting held in celebration of the 66th anniversary of the founding of the KCU; I am very happy and pleased today to see you, our proud KCU delegates, who have come from...More

President Kim Il Sung regarded children as the kings or queens of the country, loved them fervently and made them the happiest in the world. This has not been found yet in any other country. The Pyongyang Students and Children’s Palace is the epitome of his love for...More

A Chinese vaccine maker has begun COVID-19 vaccine clinical trials on minors to better understand the vaccine's safety and efficacy to a wider population, the Global Times learned on Tuesday. The China National Biotec Group (CNBG) of SinoPharm, China's leading vaccine producer with two inactivated vaccine candidates for...More